Expression of vTR harboring the mutant template (AU5) decreases cell proliferation of an avian cancer cell line. by Benedikt B. Kaufer (341018)

Pertussis specific IgG levels decrease with time. by Inonge van Twillert (503888)

Inhibition of ABCG2 decreases SP cells, but not sphere-forming ability. by Noriko Kawai (6694010)

RSV decreased the Cav-1 and TGF-β expression in liver of rats fed high-fat diet. by Hui Yang (91136)

“…High-fat diet increased the levels of Cav-1 mRNA (A) and protein (C), and level of TGF-β mRNA (B), while RSV treatment significantly decreased Cav-1 and TGF-β expression in HFD rats. …”

PPP2R5C HepKD in <i>db/db</i> mouse liver improves insulin sensitivity, decreases hyperglycemia, but worsens the dyslipidemia. by Yong-Sheng Cheng (803758)

“…<p><b>(A)</b> Hyperglycemia in <i>db/db</i> mice is decreased upon hypatocyte-specific PPP2R5C knockdown with adeno-associated virus. …”

Intracellular levels of HSPG core proteins, HS and HPSE are decreased in ER stressed MIN6 cells. by Sarita Dhounchak (10924448)

LiCl administered via 0.5% LiCl food pellets for 4 wks decreases GFAP levels in <i>Gfap</i>-R236H/+ mice. by Christine M. LaPash Daniels (796881)

“…(E) 0.5% LiCl treatment decreased <i>Gfap</i> transcript levels relative to <i>Tbp</i> in all regions except cerebellum of R236H/+ male mice (N = 4–5 mice per group). …”

List of FLC-evolved strains with different <i>ERG251</i> point mutations. by Xin Zhou (54275)

Table1_Pharmacological OGG1 inhibition decreases murine allergic airway inflammation.DOCX by Lloyd Tanner (6371633)

“…However, 8-oxoguanine DNA glycosylase-1 (OGG1), a DNA repair protein may play a central role, as OGG1 deficiency decreases both innate and allergic inflammation.…”

Decreased miR-24 sensitizes cells to apoptotic stimuli, and increases pro-apoptotic protein expression. by Tan Nguyen (278146)

“…Infected cells were selected in puromycin and decreased expression of miR-24 validated by quantitative RT-PCR (<b><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0055406#pone.0055406.s004" target="_blank">Fig S4</a></b>). …”

Down-regulation of Bim in EBV-positive cells is not due to proteosomal degradation or decreased mRNA stability. by Kostas Paschos (262658)

Proteomic analysis of DCM mouse hearts reveals activation of complement cascades and decreased protein abundance involved in glycogen metabolic processes. by Leslie Kennedy (4458544)

Plakoglobin decreases <i>in vitro</i> migration and invasion. by Zackie Aktary (481667)

Activation of mitoK_ATP channels decreased the latency time of the transjunctional currents in slice. by Jiangping Wang (281901)

“…The control experiment is shown in (<b>A1</b>). (<b>B</b>) Bar graph shows that at 6 min after exposure to DIZ, the latency time was decreased by 50% with an average of 234.54±34.43 µs (n = 13). …”

Insulin decreases the interspike interval (ISI) and cluster pause duration of mitral cell action potential activity. by Debra Ann Fadool (332114)

Pep4 overexpression decreased APCs in Vps21- and ESCRT-mutant cells after nitrogen starvation. by Zulin Wu (4451572)

“…<p><b>A.</b> The accumulation of GFP-Atg8-labeled APCs in mutant cells (<i>vps21Δ</i>, <i>snf7Δ</i>, and <i>vps4Δ</i>) slightly decreased with Pep4 overexpression. …”

Discovery of <i>N</i>‑((3<i>S</i>,4<i>S</i>)‑4-(3,4-Difluorophenyl)piperidin-3-yl)-2-fluoro-4-(1-methyl‑1<i>H</i>‑pyrazol-5-yl)benzamide (Hu7691), a Potent and Selective Akt Inhibitor That Enables Decrease of Cutaneous Toxicity by Jinxin Che (791250)

Discovery of <i>N</i>‑((3<i>S</i>,4<i>S</i>)‑4-(3,4-Difluorophenyl)piperidin-3-yl)-2-fluoro-4-(1-methyl‑1<i>H</i>‑pyrazol-5-yl)benzamide (Hu7691), a Potent and Selective Akt Inhibitor That Enables Decrease of Cutaneous Toxicity by Jinxin Che (791250)

Discovery of <i>N</i>‑((3<i>S</i>,4<i>S</i>)‑4-(3,4-Difluorophenyl)piperidin-3-yl)-2-fluoro-4-(1-methyl‑1<i>H</i>‑pyrazol-5-yl)benzamide (Hu7691), a Potent and Selective Akt Inhibitor That Enables Decrease of Cutaneous Toxicity by Jinxin Che (791250)

Discovery of <i>N</i>‑((3<i>S</i>,4<i>S</i>)‑4-(3,4-Difluorophenyl)piperidin-3-yl)-2-fluoro-4-(1-methyl‑1<i>H</i>‑pyrazol-5-yl)benzamide (Hu7691), a Potent and Selective Akt Inhibitor That Enables Decrease of Cutaneous Toxicity by Jinxin Che (791250)